How a Liver Biopsy Is Done: Procedure and Preparation

A liver biopsy is a procedure in which a doctor inserts a thin needle through the skin and into the liver, withdrawing a small cylinder of tissue for examination under a microscope. The most common version, called a percutaneous biopsy, typically takes less than a minute for the actual needle pass and is performed under local anesthesia with ultrasound guidance. Despite advances in blood tests and imaging, biopsy remains the most reliable way to diagnose many liver diseases and to gauge how much scarring has already occurred.

Why Doctors Still Order Liver Biopsies

Blood tests and imaging can tell a clinician a lot about your liver, but they cannot always pin down a specific diagnosis or show how far a disease has progressed. A biopsy gives pathologists a direct look at the tissue. For patients with hepatitis from various causes, the sample lets doctors both identify the source of the inflammation and assess how much fibrosis (scarring) has developed, two pieces of information that directly shape treatment decisions.¹ A biopsy is also used to evaluate unexplained abnormal liver enzymes, diagnose autoimmune liver diseases, assess how well a transplanted liver is functioning, and characterize liver masses that imaging alone cannot confidently classify.

Preparing for the Procedure

Preparation typically starts days before the biopsy itself. Your medical team will draw blood to check your clotting ability, focusing on your platelet count and a measure called the INR (a gauge of how quickly your blood clots). These numbers help the team decide whether you can safely undergo a needle pass through the liver. Historically, strict cutoffs were enforced, but guidelines have loosened over time. A study spanning over 500 ultrasound-guided liver biopsies found that adopting the updated 2019 guidelines did not increase bleeding events, with adverse bleeding rates staying below 1%.² Separately, a nine-year review showed that relaxing the acceptable INR up to 2.0 and the platelet floor down to 25,000 per microliter did not raise complication rates but did substantially reduce the number of patients who needed pre-procedure blood product transfusions.³

If you take blood thinners, your doctor will give you specific instructions. Prescription anticoagulants are usually stopped several days ahead. The picture for low-dose aspirin is murkier. A survey of gastroenterologists found that about three-quarters stop aspirin an average of six days before a percutaneous liver biopsy, even though most of those same doctors reported never having seen a bleed in a patient who was on aspirin.⁴ The precaution sometimes delays the procedure, and the evidence supporting it is thin, so practices vary from one center to the next. You will also be told to fast for a certain number of hours beforehand and to arrange a ride home, since you cannot drive after sedation.

The Percutaneous Biopsy Step by Step

This is the standard approach and the one most patients receive. You lie on your back or slightly on your left side, and the doctor uses an ultrasound probe to locate a safe path into the liver, avoiding large blood vessels and the gallbladder. A local anesthetic, usually lidocaine buffered with a small amount of sodium bicarbonate, is injected into the skin and then deeper into the tissue layers down to the liver capsule itself.⁵

When the area is numb, the doctor asks you to hold your breath, typically in expiration. Holding your breath prevents the diaphragm from moving the liver during the needle pass and reduces the chance of injuring the lung lining above. The biopsy needle, commonly an 18-gauge spring-loaded cutting device, is then advanced under ultrasound guidance. Once the doctor confirms the needle tip has crossed the liver capsule, the cutting mechanism fires and captures a slender core of tissue. The whole firing sequence takes a fraction of a second. Sometimes two or three passes are needed to get enough tissue. If you have trouble holding your breath, the doctor can let you breathe once the needle tip is anchored deep enough in the liver tissue before firing.⁵

While ultrasound is by far the most common imaging tool used during the procedure, some biopsies are guided by CT scan, and a small number by MRI. These alternatives tend to be reserved for cases where the target is hard to see on ultrasound.

When the Standard Route Is Not an Option

Some patients cannot safely have a needle pushed through the abdominal wall. Large-volume ascites (fluid in the abdomen), severe clotting problems, and extreme obesity are the most common reasons. In these situations, doctors turn to alternative routes.

Transjugular Liver Biopsy

Instead of going through the skin over the liver, the doctor accesses the liver from the inside, through a vein. A catheter is threaded through the jugular vein in the neck, guided down into the heart’s right side, and then into one of the hepatic veins that drain the liver. A special biopsy needle is advanced through that catheter to collect tissue. Because the needle enters the liver from within a blood vessel, any bleeding drains back into the vein rather than into the abdominal cavity, making it much safer for patients who cannot clot normally.⁶ The transjugular route is indicated for patients with coagulopathy, ascites, morbid obesity, suspected peliosis hepatis, or those who are already having a related vascular procedure.⁷

Endoscopic Ultrasound-Guided Biopsy

A newer option uses an endoscope equipped with an ultrasound probe. While the patient is sedated, the scope is passed down the throat and into the upper part of the small intestine, from where the needle can reach the liver through the gut wall. A systematic review found the approach achieves a histologic diagnosis in roughly 94% of cases with an adverse event rate of about 2%.⁸ When tissue from both lobes of the liver is sampled, the total specimen length can exceed what percutaneous or transjugular methods typically collect.⁹ The endoscopic approach also tends to cause less post-procedure pain and a shorter hospital stay compared to percutaneous biopsy.¹⁰ That said, it requires deep sedation and an endoscopy suite, and it remains less widely available than percutaneous biopsy.

What the Pain Is Actually Like

One of the biggest worries patients have is pain, and it is worth being honest about this. In one study, 84% of patients reported pain thirty minutes after the biopsy, with pain at the biopsy site, in the right shoulder (referred pain from irritation of the diaphragm), or both. By 24 hours, about 39% still had some pain. Women and patients with higher pre-procedure anxiety levels tended to report more intense pain. The researchers concluded that local anesthesia combined with mild sedation often provides insufficient relief and that more effective pain control should be considered.¹¹

Interestingly, the fear of pain consistently outstrips the pain itself. A separate study measured expected pain versus experienced pain and found a dramatic gap: patients expected a pain score of about 60 out of 100 beforehand but reported only about 22 out of 100 during the procedure. Women anticipated significantly more pain than men, but their actual pain scores were no different.¹² This suggests that a clear, calm explanation of what to expect can meaningfully reduce distress before the procedure even begins.

Recovery and What to Watch For

After the needle is withdrawn, you will be asked to lie on your right side (the side of the puncture) for a period of time. Many hospitals have traditionally kept patients flat for four to six hours, monitoring vitals and watching for signs of bleeding. Research has questioned whether that long observation is necessary. A randomized trial comparing two-hour and six-hour recovery windows found no significant difference in complication rates between the groups. Pain at the puncture site was the most common complaint, occurring in about two-thirds of patients. The most serious complication observed was a subcapsular liver hematoma, which occurred in about 1.6% of participants regardless of recovery group.¹³ Some centers now allow stable patients to go home sooner than in the past, though policies vary.

Once home, you are usually told to avoid heavy lifting and strenuous activity for a day or two. Any fever, worsening abdominal pain, dizziness, or shoulder pain after discharge warrants a call to your doctor, as these can signal bleeding or a bile leak.

How Common Are Serious Complications

Liver biopsy is generally safe, but it is an invasive procedure and carries real, if small, risks. A systematic review and meta-analysis pooling data from studies of percutaneous biopsy in patients with chronic liver disease found a major complication rate of roughly 2.4%. Breaking that down, the rate of major bleeding was about 0.5%, hospitalization was needed in about 0.7% of cases, moderate-to-severe pain in about 0.3%, and the mortality rate was approximately 0.01%.¹⁴ One interesting finding from that analysis: younger patients actually had higher rates of hospitalization and major bleeding, which runs counter to what many people assume.

Most bleeding complications show up within the first 24 hours. Case reports exist of delayed bleeds occurring days later, though this is exceptionally rare. One documented case described significant bleeding ten days after the biopsy, a delay not previously reported in the literature.¹⁵ As a practical point, it is worth knowing that biopsying a mass sitting just beneath the liver capsule does not appear to raise bleeding risk compared to biopsying deeper lesions or taking random samples.¹⁶

Situations That Complicate the Decision

Most contraindications to percutaneous liver biopsy are relative rather than absolute, and many were established decades ago when needles were larger and imaging guidance was limited. British Society of Gastroenterology guidelines note that risks can often be managed rather than simply refused.¹⁷ Patient cooperation matters a great deal: any involuntary movement while the needle is inside the liver can tear the capsule, so anxious patients may receive sedation with midazolam. When the bile ducts are dilated (a sign of obstruction), the transjugular route is preferred to avoid bile leaking into the abdomen. Large-volume ascites is another classic reason to consider the transjugular approach, though draining the fluid first and then proceeding with a percutaneous biopsy is also an option. Suspected amyloidosis is often listed as a contraindication due to older reports of fatal hemorrhage, but the same guidelines suggest that if suspicion is low and the liver is enlarged for unclear reasons, biopsy can proceed using the transjugular route.¹⁷

Why Sample Size Matters More Than You Might Think

A liver biopsy produces a tiny cylinder of tissue, typically a couple of centimeters long and about a millimeter wide. Pathologists need enough of that cylinder to make a confident diagnosis. The gold standard for evaluating fibrosis and inflammation relies on counting small structures called portal tracts in the sample. Guidelines from the American Association for the Study of Liver Diseases set the bar at 11 or more portal tracts for an adequate specimen.¹⁸ Practically, that translates to needing a sample at least about 15 mm long when using a standard 16-gauge needle.¹⁹ Samples that are too short or fragmented can lead to understaging fibrosis, because scarring is not evenly distributed throughout the liver. If the sample misses a patch of dense fibrosis, the pathologist might classify you as having less disease than you actually do.

Even with an adequate sample, interpretation is not perfectly reproducible. A study of 125 liver biopsies sent for a second pathologist’s opinion found full agreement in only about a third of cases. Major disagreements occurred in roughly 28% of biopsies, many of them involving cholestatic disorders or the question of whether cirrhosis was present. This is not a reason to distrust biopsy, which is still the most detailed window into what is happening in the liver, but it is a reminder that pathology is an interpretive skill, not a mechanical readout.

How Non-Invasive Tests Compare

Given that biopsy carries discomfort and a small risk of complications, clinicians and patients alike are interested in blood tests and imaging that can substitute for it. Blood-based scoring systems and a technology called transient elastography (which uses ultrasound waves to measure liver stiffness) have become routine first-line assessments for fibrosis.²⁰ These tests are excellent at identifying people with little or no fibrosis and those with advanced cirrhosis. The trouble is in the middle stages. A recent study found that when the two most commonly used non-invasive tools both indicated no significant fibrosis, roughly 31% of those patients actually had moderate-to-advanced fibrosis on biopsy.²¹ That is a meaningful miss rate, and it explains why biopsy persists as the reference standard, particularly when the clinical stakes are high or when non-invasive results seem at odds with the rest of the picture.

Non-invasive tests are steadily improving, and for many patients they now spare the need for a needle. But whenever there is diagnostic uncertainty, a treatment decision that hinges on the exact stage of fibrosis, or a suspected condition that only tissue examination can confirm (autoimmune hepatitis, drug-induced liver injury, infiltrative diseases), biopsy remains the tool that provides the most definitive answer.

Liver Biopsy in Children

Children undergo liver biopsies for many of the same reasons adults do, including evaluation of elevated liver enzymes, assessment of liver transplant health, and diagnosis of metabolic disorders. The procedural technique is essentially the same, performed percutaneously under ultrasound guidance with a cutting needle. The key difference is sedation. In a large series of nearly 600 pediatric liver biopsies, about half were performed under sedation and the other half under general anesthesia. Major complications occurred in 1.7% of cases, including symptomatic bleeding in about 1.3% and one pneumothorax. There were no procedure-related deaths.²² Ketamine-based sedation administered by a radiologist has also been used successfully in children, with one study of 35 pediatric liver biopsies under ketamine reporting no major adverse events and an average sedation time of about 39 minutes.²³

Parents should know that the complication profile in children is broadly similar to that in adults. The procedure itself is quick, but the sedation and recovery add time. Most children are monitored for several hours afterward and can go home the same day if stable.

When a Second Pathology Opinion Makes a Difference

Once the tissue is collected, it goes to a pathologist who stains it, examines it under a microscope, and issues a report describing what they see. In straightforward cases this report is clear-cut, but liver pathology can be genuinely ambiguous. The second-opinion study mentioned earlier found that about 38% of biopsies had minor disagreements between two pathologists and 28% had major ones, meaning the revised diagnosis would have changed management. The hardest calls tended to involve distinguishing between overlapping cholestatic conditions and determining whether the tissue had crossed the threshold into cirrhosis. If your biopsy result surprises your doctor or does not match the clinical picture, asking for a second pathology review is a reasonable step. The added cost is real, but so is the potential for a more accurate diagnosis guiding better treatment.